CD44 and small cell lung carcinoma: In small cell lung cancers, it was shown that activation of CD44-MAPK-PI3K signalling results in the increased expression of urokinase plasminogen activator and its receptor, uPAR, and MDR1, resulting in enhanced invasive and multi-drug resistant cancer phenotypes [30].